Wei Wang
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Physiology top 2%
Papers in
-
- RNA modifications and cancer 22
- Cancer therapeutics and mechanisms 18
- Epidemiology 67
- Herpesvirus Infections and Treatments 15
- Co-authors
- Liyan Zhang (1 shared paper)Victor Samokhvalov (1 shared paper)Wendy Keung (1 shared paper)Hua Tian (19 shared papers)Gary D. Lopaschuk (1 shared paper)Shaoguo Ru (18 shared papers)Jianzhong Xiao (1 shared paper)Gangyi Liu (1 shared paper)
- Journals
- Scientific Reports (12 papers)PLoS ONE (8 papers)Medicine (6 papers)Frontiers in Oncology (6 papers)Ecotoxicology and Environmental Safety (6 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Wei Wang
505 papers receiving 6.3k citations
Wei Wang's Hit Papers
Peers
Comparison fields: 5 of 185
- Cancer Research 770
- Physiology 159
- Molecular Biology 2.4k
- Immunology 645
- Biological Psychiatry 62
Countries citing papers authored by Wei Wang
This map shows the geographic impact of Wei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Wang more than expected).
Fields of papers citing papers by Wei Wang
This network shows the impact of papers produced by Wei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Wang. The network helps show where Wei Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 567 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 221 | |
| 2 | 2005 | 178 | |
| 3 | Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy Hit paper breakdown → | 2024 | 169 |
| 4 | 2004 | 142 | |
| 5 | 2020 | 140 | |
| 6 | 2012 | 111 | |
| 7 | 2020 | 104 | |
| 8 | 2006 | 101 | |
| 9 | 2007 | 97 | |
| 10 | 2018 | 93 | |
| 11 | 2019 | 91 | |
| 12 | 2019 | 88 | |
| 13 | 2017 | 87 | |
| 14 | 2013 | 85 | |
| 15 | 2021 | 73 | |
| 16 | 2013 | 67 | |
| 17 | 2020 | 67 | |
| 18 | 2012 | 67 | |
| 19 | 2022 | 66 | |
| 20 | Zr‐MOF Carrier‐Enhanced Dual‐Mode Biosensing Platforms for Rapid and Sensitive Diagnosis of Mpox Hit paper breakdown → | 2024 | 63 |
About Wei Wang
Wei Wang is a scholar working on Molecular Biology, Epidemiology, Cancer Research, Surgery and Pulmonary and Respiratory Medicine, having authored 567 papers that have together received 6.5k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (39 papers), RNA modifications and cancer (22 papers), Thyroid Disorders and Treatments (20 papers), MicroRNA in disease regulation (19 papers), Cancer therapeutics and mechanisms (18 papers), Herpesvirus Infections and Treatments (15 papers), Lymphoma Diagnosis and Treatment (15 papers) and Reproductive biology and impacts on aquatic species (14 papers). The work is most often cited by research in Cancer Research (770 citations), Physiology (159 citations), Molecular Biology (2.4k citations), Immunology (645 citations) and Biological Psychiatry (62 citations). Wei Wang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Liyan Zhang, Victor Samokhvalov, Wendy Keung, Hua Tian, Gary D. Lopaschuk, Shaoguo Ru, Jianzhong Xiao, Gangyi Liu, Quan Shi and Qi Zhou. Their work appears in journals such as Scientific Reports, PLoS ONE, Medicine, Frontiers in Oncology and Ecotoxicology and Environmental Safety.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.